ODT

Odonate Therapeutics Stock Price

3.31
-0.01 (-0.3%)
3.31

Low
3.02

52 Week Range

High
46.4999

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Odonate Therapeutics Inc ODT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.01 -0.3% 3.31 07:36:17
Open Price Low Price High Price Close Price Prev Close
3.32
Bid Price Ask Price Spread News
3.26 3.31 0.05 - -
Trades Volume Avg Volume 52 Week Range
11 639 578,214 3.02 - 46.4999
Last Trade Time Type Quantity Stock Price Currency
08:15:28 1 $ 3.31 USD

Odonate Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 127.57M 38.54M 19.80M $ - $ - -4.09 -5.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Odonate Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ODT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.413.473.183.28923,410-0.10-2.93%
1 Month3.034.973.023.7710,937,2760.289.24%
3 Months24.5728.413.024.554,355,475-21.26-86.53%
6 Months16.2028.413.025.852,329,747-12.89-79.57%
1 Year28.3246.49993.027.381,268,194-25.01-88.31%
3 Years20.7246.49993.029.38475,759-17.41-84.03%
5 Years23.0046.49993.029.67433,264-19.69-85.61%

Odonate Therapeutics Description

Odonate Therapeutics Inc is a US-based pharmaceutical company that is engaged in the development of therapeutics which improves and extends the lives of patients with cancer. The company mainly focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs, taxanes, which are widely used in the treatment of cancer including breast cancer. The key product of the company is Tesetaxel which is chemotherapy for oral administration with a low pill burden for various types of cancers.


Your Recent History
NASDAQ
ODT
Odonate Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.